LPL Financial’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Sell
111,325
-25,058
-18% -$2.3M ﹤0.01% 1992
2025
Q4
$12.3M Buy
136,383
+7,182
+6% +$681K ﹤0.01% 1755
2025
Q3
$12.7M Buy
129,201
+11,981
+10% +$1.19M ﹤0.01% 1664
2025
Q2
$10.7M Sell
117,220
-2,861
-2% -$277K ﹤0.01% 1671
2025
Q1
$13.6M Buy
120,081
+20,360
+20% +$2.18M 0.01% 1399
2024
Q4
$10.5M Buy
99,721
+10,122
+11% +$1.09M ﹤0.01% 1503
2024
Q3
$9.67M Sell
89,599
-5,236
-6% -$571K ﹤0.01% 1488
2024
Q2
$10.3M Sell
94,835
-21,236
-18% -$2.5M 0.01% 1357
2024
Q1
$15.3M Sell
116,071
-9,425
-8% -$1.18M 0.01% 1071
2023
Q4
$15.3M Buy
125,496
+1,155
+0.9% +$129K 0.01% 1000
2023
Q3
$14M Buy
124,341
+6,865
+6% +$872K 0.01% 972
2023
Q2
$17.1M Buy
117,476
+10,969
+10% +$1.49M 0.01% 859
2023
Q1
$13.8M Buy
106,507
+7,584
+8% +$952K 0.01% 924
2022
Q4
$12.6M Buy
98,923
+2,730
+3% +$317K 0.01% 902
2022
Q3
$10.1M Buy
96,193
+21,847
+29% +$2.4M 0.01% 947
2022
Q2
$7.81M Buy
74,346
+8,348
+13% +$990K 0.01% 1104
2022
Q1
$8.44M Buy
65,998
+11,241
+21% +$1.35M 0.01% 1093
2021
Q4
$6.75M Buy
54,757
+2,315
+4% +$303K 0.01% 1257
2021
Q3
$7.45M Buy
52,442
+3,331
+7% +$490K 0.01% 1121
2021
Q2
$7.67M Buy
49,111
+1,578
+3% +$256K 0.01% 1068
2021
Q1
$7.39M Buy
47,533
+1,759
+4% +$272K 0.01% 993
2020
Q4
$6.85M Buy
45,774
+2,677
+6% +$378K 0.01% 940
2020
Q3
$5.7M Sell
43,097
-288
-0.7% -$37.6K 0.01% 886
2020
Q2
$5.03M Buy
43,385
+9,742
+29% +$1.12M 0.01% 876
2020
Q1
$3.3M Sell
33,643
-8,207
-20% -$1.08M 0.01% 921
2019
Q4
$6.08M Buy
41,850
+16,183
+63% +$2.23M 0.01% 761
2019
Q3
$3.42M Sell
25,667
-2,591
-9% -$335K 0.01% 963
2019
Q2
$3.23M Buy
28,258
+2,781
+11% +$326K 0.01% 981
2019
Q1
$3.16M Buy
25,477
+3,584
+16% +$407K 0.01% 947
2018
Q4
$2.21M Buy
21,893
+7,196
+49% +$809K 0.01% 1023
2018
Q3
$1.88M Sell
14,697
-5,242
-26% -$623K ﹤0.01% 1230
2018
Q2
$2.16M Buy
19,939
+271
+1% +$29.5K 0.01% 1091
2018
Q1
$2.08M Buy
19,668
+1,721
+10% +$200K 0.01% 1096
2017
Q4
$2.1M Sell
17,947
-447
-2% -$50.5K 0.01% 1028
2017
Q3
$2.09M Sell
18,394
-10,618
-37% -$1.23M 0.01% 967
2017
Q2
$3.62M Buy
+29,012
New +$3.44M 0.01% 668
2016
Q4
Sell
-8,219
Closed -$1.03M 2792
2016
Q3
$1.03M Buy
8,219
+634
+8% +$78.3K 0.01% 1166
2016
Q2
$897K Sell
7,585
-35,723
-82% -$4.04M 0.01% 1249
2016
Q1
$4.46M Sell
43,308
-1,423
-3% -$138K 0.01% 781
2015
Q4
$4.51M Buy
44,731
+25,802
+136% +$2.52M 0.01% 768
2015
Q3
$1.75M Buy
18,929
+2,793
+17% +$280K 0.01% 899
2015
Q2
$1.7M Sell
16,136
-906
-5% -$100K 0.01% 1001
2015
Q1
$1.92M Sell
17,042
-1,122
-6% -$128K 0.01% 934
2014
Q4
$2M Buy
18,164
+5,257
+41% +$554K 0.01% 872
2014
Q3
$1.26M Sell
12,907
-241
-2% -$23.7K 0.01% 1127
2014
Q2
$1.33M Buy
13,148
+1,198
+10% +$117K 0.01% 1139
2014
Q1
$1.1M Sell
11,950
-586
-5% -$54K 0.01% 1206
2013
Q4
$1.13M Sell
12,536
-35
-0.3% -$3.03K 0.01% 1162
2013
Q3
$1.07M Sell
12,571
-476
-4% -$37.5K 0.01% 1152
2013
Q2
$949K Buy
+13,047
New +$976K 0.01% 1158

Other funds holding ZBH

LPL Financial's ZBH Position: Q1 2026 in Review

LPL Financial reduced its Zimmer Biomet (ZBH) stake by 18% in Q1 2026, selling an estimated $2.3M and leaving 111,325 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1992.

LPL Financial first reported a position in ZBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $17.1M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • LPL Financial held 111,325 shares of Zimmer Biomet worth $10.1M as of Q1 2026.
  • LPL Financial sold 25,058 Zimmer Biomet shares in Q1 2026, an estimated $2.3M.
  • Zimmer Biomet made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #1992 holding.
  • LPL Financial first reported a position in Zimmer Biomet in Q2 2013 and has held it in 50 quarters since.
  • LPL Financial's Zimmer Biomet position peaked at $17.1M in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.